Cargando…

Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging

PURPOSE: The aim of this work was to evaluate the prognostic value of tumor length and diameter for patients with esophageal squamous cell cancer (ESCC) treated with definitive (chemo)radiotherapy to identify potential indicators for separate nonsurgical T staging, which are needed in clinical pract...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hongyao, Wu, Shengxi, Luo, Hesan, Chen, Chuyun, Lin, Lianxing, Huang, Hecheng, Xue, Renliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797578/ https://www.ncbi.nlm.nih.gov/pubmed/31486278 http://dx.doi.org/10.1002/cam4.2532

Ejemplares similares

YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma
por: Dai, Honghai, et al.
Publicado: (2019)

Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy
por: Haefner, Matthias F., et al.
Publicado: (2015)

Aging‐related prognosis analysis of definitive radiotherapy for very elderly esophageal cancer
por: Zhou, Yong‐Chun, et al.
Publicado: (2018)

Prognostic value of baseline (18)F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
por: Xia, Lianshuang, et al.
Publicado: (2023)

Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design
por: Zheng, Yuyan, et al.
Publicado: (2021)

Targeting LMW‐PTP to sensitize melanoma cancer cells toward chemo‐ and radiotherapy
por: Lori, Giulia, et al.
Publicado: (2018)

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma
por: Guan, Xin, et al.
Publicado: (2020)

Feasibility of definitive chemoradiation therapy with nedaplatin and 5-fluorouracil in elderly patients with esophageal squamous cell carcinoma: A retrospective study
por: Watanabe, Akinori, et al.
Publicado: (2018)

Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
por: Luo, He-San, et al.
Publicado: (2019)

Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer
por: Zingg, Urs, et al.
Publicado: (2009)

Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2018)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

S-nitrosothiols and H(2)S donors: Potential chemo-therapeutic agents in cancer
por: Reis, Adriana Karla Cardoso Amorim, et al.
Publicado: (2019)

Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
por: Yuan, Shuanghu Tiger, et al.
Publicado: (2014)

Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus
por: Derby, Sarah, et al.
Publicado: (2021)

Involvement of DPP3 in modulating oncological features and oxidative stress response in esophageal squamous cell carcinoma
por: Arora, Mohit, et al.
Publicado: (2023)

Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma
por: Wennerström, E. Christina M., et al.
Publicado: (2016)

Serum DSG2 as a potential biomarker for diagnosis of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Liu, Yin-Qiao, et al.
Publicado: (2022)

PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy
por: Sistonen, Heli J., et al.
Publicado: (2023)

Cachexia in cancer: what is in the definition?
por: Vanhoutte, Greetje, et al.
Publicado: (2016)

Sequential boost of intensity‐modulated radiotherapy with chemotherapy for inoperable esophageal squamous cell carcinoma: A prospective phase II study
por: Fan, Xing‐Wen, et al.
Publicado: (2020)

ZFPM2-AS1 facilitates cell growth in esophageal squamous cell carcinoma via up-regulating TRAF4
por: Sun, Gaozhong, et al.
Publicado: (2020)

The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
por: Dreyfuss, Alexandra D., et al.
Publicado: (2021)

Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
por: Mitani, Seiichiro, et al.
Publicado: (2019)

Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy
por: Huang, Zhiyu, et al.
Publicado: (2022)

Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
por: Aas, Kirsti, et al.
Publicado: (2021)

Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy
por: Kagawa, Tomo, et al.
Publicado: (2018)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

Hopkins criteria for residual disease assessment after definitive radiotherapy in nasopharyngeal carcinoma
por: Liu, Yang, et al.
Publicado: (2019)

Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database
por: Yu, Jing, et al.
Publicado: (2018)

Investigation of IL-4, IL-10, and HVEM polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
por: Chen, Shuchen, et al.
Publicado: (2020)

A three-gene signature and clinical outcome in esophageal squamous cell carcinoma
por: Sun, Ling-Ling, et al.
Publicado: (2015)

Prognostic impact of MutT homolog‐1 expression on esophageal squamous cell carcinoma
por: Akiyama, Shingo, et al.
Publicado: (2016)

The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study
por: Haring, Martijn P. D., et al.
Publicado: (2019)

Nonsurgical Treatment for Localized Hepatocellular Carcinoma
por: Kennedy, Andrew S., et al.
Publicado: (2014)

Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
por: Connor, Steve, et al.
Publicado: (2021)

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy
por: Rühle, Alexander, et al.
Publicado: (2022)

Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor: Findings from the ESCCAPE multicountry case‐control studies
por: Narh, Clement T., et al.
Publicado: (2021)

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
por: Hsieh, Jason Chia‐Hsun, et al.
Publicado: (2021)

Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
por: Xu, Xiujuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jua40ngd74d60engn0e9ias9kd